Clinical Research/Studies

Is there clinical research going on for Aniridia?

Current research on aniridia deals with an oral drug named Translarna™ that could potentially prevent or reverse the clinical eye-related manifestations of aniridia.

SOURCE: Emory University - Department of Human Genetics in collaboration with ThinkGenetic • • DATE UPDATED: 2016-06-24


This content comes from a hidden element on this page.

The inline option preserves bound JavaScript events and changes, and it puts the content back where it came from when it is closed.

Remember Me